Spotlight
Topic
Brand Insights
Subscribe
- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Gathering Light
Article
Pharmaceutical Executive
Pharmaceutical ExecutivePharmaceutical Executive-06-01-2001
Volume 0
Issue 0
I intended to write an entirely different column this month. Something like, What the Bush administration has done for you-the pharmaceutical industry-lately. Such as making it harder to do stem-cell research and pursuing an investigation into antigeneric activities. But something else happened. My father died. Now I have no room left in my mind or heart for other matters.
Articles in this issue
Industry Under Investigation
Covering the Bases
Emotion - The New Brand Integrator
For Love of the Game
Field of Dreams
Workshop: Access Options
Emotion - The New Brand Integrator
Rx-to-OTC: Unwanted Attention
Emotion - Biotech Renaissance Man
Biotech Renaissance Man
Relocation: Coming to America
Biotechnology: German Industry Beefs Up
Stocks: Catching the Market Blues
Gathering Light
Recent Videos
Related Content
Beyond the Birthrate: The Societal Costs of Maternal Mortality
September 6th 2024Podcast
Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
